- Home
- CAC vs EYPT Comparison
CAC vs EYPT Comparison
Compare CAC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CAC | EYPT |
|---|---|---|
| Founded | 1875 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 680.5M | 1.5B |
| IPO Year | 1997 | 2005 |
Fundamental Metrics
Financial Performance| Metric | CAC | EYPT |
|---|---|---|
| Price | $45.66 | $17.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $47.33 | $29.60 |
| AVG Volume (30 Days) | 90.3K | ★ 1.3M |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | ★ 3.66% | N/A |
| EPS Growth | ★ 9.13 | N/A |
| EPS | ★ 3.49 | N/A |
| Revenue | ★ $215,172,000.00 | $42,339,000.00 |
| Revenue This Year | $44.50 | N/A |
| Revenue Next Year | $7.03 | N/A |
| P/E Ratio | $13.16 | ★ N/A |
| Revenue Growth | ★ 27.50 | N/A |
| 52 Week Low | $34.53 | $3.91 |
| 52 Week High | $46.80 | $19.11 |
Technical Indicators
Market Signals| Indicator | CAC | EYPT |
|---|---|---|
| Relative Strength Index (RSI) | 76.70 | 66.36 |
| Support Level | $43.60 | $16.52 |
| Resistance Level | $46.80 | $17.40 |
| Average True Range (ATR) | 1.18 | 1.08 |
| MACD | 0.27 | 0.02 |
| Stochastic Oscillator | 89.52 | 71.27 |
Price Performance
Historical ComparisonAbout CAC Camden National Corporation
Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.